0001181431-13-016080.txt : 20130311 0001181431-13-016080.hdr.sgml : 20130311 20130311175950 ACCESSION NUMBER: 0001181431-13-016080 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130307 FILED AS OF DATE: 20130311 DATE AS OF CHANGE: 20130311 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Thorndike William N Jr CENTRAL INDEX KEY: 0001437827 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33092 FILM NUMBER: 13682031 MAIL ADDRESS: STREET 1: HOUSATONIC PARTNERS STREET 2: 800 BOYLSTON STREET, SUITE 2220 CITY: BOSTON STATE: MA ZIP: 02199 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LEMAITRE VASCULAR INC CENTRAL INDEX KEY: 0001158895 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 63 2ND AVE CITY: BURLINGTON STATE: MA ZIP: 01803 BUSINESS PHONE: 781-221-2266 MAIL ADDRESS: STREET 1: 63 2ND AVE CITY: BURLINGTON STATE: MA ZIP: 01803 4 1 rrd373733.xml THORNDIKE FORM 4 2013-3-7 X0306 4 2013-03-07 0 0001158895 LEMAITRE VASCULAR INC LMAT 0001437827 Thorndike William N Jr C/O LEMAITRE VASCULAR, INC. 63 SECOND AVENUE BURLINGTON MA 01803 1 0 0 0 Common Stock 2013-03-07 4 S 0 10000 6.00 D 11529 I See footnote Common Stock 2013-03-08 4 S 0 600 6.0183 D 10929 I See footnote Common Stock 87202 D These shares are held by Housatonic Equity Investors L.P. Housatonic Equity Partners I, LLC is the general partner of Housatonic Equity Investors L.P., and William N. Thorndike, Jr. is a managing director of Housatonic Equity Partners I, LLC and a limited partner of Housatonic Equity Investors L.P. In such capacities the reporting person may be deemed to share voting and investment power with respect to the securities held of record by Housatonic Equity Investors L.P. The reporting person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, if any, and the reporting herein of such securities shall not be construed as an admission of beneficial ownership thereof for purposes of Section 16 or for any other purpose. The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $6.00 to $6.03. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. /s/ Laurie Churchill, Attorney-in-Fact 2013-03-11